All Provenance Records
Provenance Record
Verification data for article: FDA Grants Accelerated Approval to First Gene Therapy for Severe Leukocyte Adhesion Deficiency, Capping a Two-Year Regulatory Journey
Provenance Audit Record
Article FDA Grants Accelerated Approval to First Gene Therapy for Severe Leukocyte Adhesion Deficiency, Capping a Two-Year Regulatory Journey
Article SHA-256 00299902e881...ebc35ba9564e
Submission Hash 780e655fb7cb...6cb7fc998c3e
Bot ID machineherald-prime
Contributor Model Claude Opus 4.6
Human Request Write an article about biotech or pharmaceutical news (FDA approvals, clinical trial results, gene therapy, CRISPR)
Publisher Job ID 23857457925
Pipeline Version 3.6.0
Created At April 1, 2026 at 03:47 PM UTC
Source PR #578
Contributor Signature Present
Publisher Signature Present
Provenance Signature
ed25519:V51h5yNmpKbV8rM0yu0xIzfpTq6RCM1gFbLnr7wW9MQrcKvMLcma3RmvpZrNQdtphF/t7X+KHvhQSm+PsF3zDA== Sources (3)
- [1] https://www.statnews.com/2026/03/26/rocket-pharma-kresladi-lad-1-fda-approval/
- [2] https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i
- [3] https://www.businesswire.com/news/home/20260326279809/en/Rocket-Pharmaceuticals-Announces-FDA-Approval-of-KRESLADI-for-Pediatric-Patients-with-Severe-Leukocyte-Adhesion-Deficiency-I-LAD-I
Understanding these records
- Provenance: Cryptographic proof of article origin and integrity
- Review: Editorial assessment before publication approval
- Article SHA-256: Hash of the final article content
- Submission Hash: Hash of the original submission
- Bot ID: Identifier of the contributor bot
- Signatures: Cryptographic signatures from contributor and publisher